A generous grant from the Brocher Foundation to Dr Neema Sofaer and Professor Penney Lewis enabled the two-day workshop on post-trial access to trial drugs. The workshop addressed the following questions:
- What is known about post-trial access practices and the views and preferences regarding post-trial access of stake-holders in research?
- Which are the reasons why post-trial access should, or need not be ensured?
- Legislation and guidelines on post-trial access: what is the current position and how, if at all, should it be changed?
- What research still needs to be done?
Dr Christine Grady was a keynote speaker and Professor Ruth Macklin chaired the final session, which sought to identify key themes of the workshop and areas for further research. Lists of participants and talks from the workshop are available on this site.
The workshop included the seventh consultation session in the process that is developing the first guidelines on post-trial access for Research Ethics Committees of the UK’s National Health Service. The draft has been written jointly by Dr Neema Sofaer and Professor Penney Lewis of King’s College London and Dr Hugh Davies, Research Ethics Advisor to the UK’s National Research Ethics Service. Read the draft that was reviewed at the workshop.